Transforming Therapeutic Investments
Welcome to the future of dermatologic biotech investment consulting. MTC³ is launching a revolutionary approach to empower investment decisions with direct-to-expert interactions.
Our Services
Strategic Sessions offering expert consulting
Rapid Response Insights offering on-demand answers
Dynamic forums offering adaptive presentations
Apex Access offering tailored service retainer
Globally Recognized Expertise
Our team is composed of world-renowned thought leaders in dermatologic and inflammatory disease, bringing unparalleled expertise to your investment strategies.
Kenneth B Gordon, MD
Richard GB Langley, MD
Bruce Strober, MD, PhD
Richard Warren,
MBChB (Hons), PhD
Joseph Merola, MD, MMSc
Why Choose MTC³
Unmatched collective expertise in dermatologic therapeutic investments
Multi-disciplinary analysis of market trends and emerging therapies
Personalized approach tailored to your investment needs
Launching Fall 2024
Be among the first to access our groundbreaking services.
Gain Priority Access
Exclusive updates on MTC³ launch
Early bird access to our service suite
Invitation to launch event
